| Financial Year |
March 31 2023 |
| Monetary Funds |
158,834,113.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
204,517,854.39 |
| Accounts Receivable |
454,737,906.79 |
| Advances to Suppliers |
28,528,792.95 |
| Other Receivables |
34,207,861.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,070,020,522.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
700,000.00 |
| Other Current Assets |
9,124,467.10 |
| Total Current Assets |
1,980,174,430.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
300,000.00 |
| Long-term Equity Investment |
7,963,094.98 |
| Investment Properties |
-- |
| Fixed Assetes |
969,435,742.17 |
| Under-construction Projects |
421,153,848.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
147,233,381.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
36,770,050.99 |
| Deferred Income Tax Assets |
49,810,404.62 |
| Other Non-Current Assets |
5,468,892.67 |
| Sub-Total of Non-Current Assets |
1,832,251,422.99 |
| Total Assets |
3,812,425,853.10 |
| Short-Term Loans |
698,501,718.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
289,612,016.55 |
| Accounts Payable |
848,555,460.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,714,781.07 |
| Taxes Payable |
21,806,784.52 |
| Interest Payable |
9,950,781.98 |
| Dividend Payable |
3,430,000.00 |
| Other payables |
643,567,005.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
150,838,989.31 |
| Other Current Liabilities |
182,325,732.61 |
| Sub-Total of Current Liabilities |
3,087,420,829.93 |
| Long-term Loans |
358,049,524.19 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,066,328.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,147,564.00 |
| Deferred Income Tax Liabilities |
24,515,623.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
534,410,965.79 |
| Total Liabilities |
3,621,831,795.72 |
| Paid-In Capital(Or Share Stock) |
495,612,000.00 |
| Capital Surplus |
591,104,231.86 |
| Surplus Reserve |
60,364,309.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-950,456,693.19 |
| Minority Stockholder's Interest |
-1,614,899.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
192,208,956.64 |
| Owner's Equity（Stockholder's Equity） |
190,594,057.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,812,425,853.10 |
